Partner Content Partner Content Formulation & Drug Delivery Series US Join 250+ pharmaceutical leaders, experts & researchers
Partner Content Partner Content Device advancements to be discussed at the Respiratory Drug ... Device advancements to be discussed
Partner Content Partner Content Key Opinion Leaders to present at the Respiratory Drug Deliv... Respiratory Drug Delivery
Partner Content Partner Content Three Interactive Sessions to take place at the Respiratory ... Interactive Sessions at RDD
Events Partner Content SMi’s 10th Annual Biosimilars Conference Biosimilars Conference, London, Sept 2019
News Novartis sheds MorphoSys staff, sites after pelabresib delay Novartis has confirmed it will shut down two MorphoSys sites in Germany and the US, with the loss of around 330 jobs, by the end of next year.
Digital Sponsored The AI effect in pharma commercial strategy: From data to re... Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
